A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People
Condition: Pneumococcal Disease Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine; Biological: control pneumococcal polysaccharide vaccine Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials